发现好书期刊,享受阅读乐趣

海量图书期刊资源,随时随地畅享阅读乐趣

A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study

A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study

Furie, R. A.; Leon, G.; Thomas, M.; Petri, M. A.; Chu, A. D.; Hislop, C.; Martin, R. S.; Scheinberg, M. A.
  • 期刊名称Annals of the Rheumatic Diseases
  • 作者Furie, R. A.; Leon, G.; Thomas, M.; Petri, M. A.; Chu, A. D.; Hislop, C.; Martin, R. S.; Scheinberg, M. A.
  • 印刷ISSN0003-4967
  • 文件大小1511.06KB
  • 发表时间2014-04-19
  • DOI10.1136/annrheumdis-2013-205144
← 返回【学霸图书馆】主页